Atlas/Blue Wolf's Continuous Refusals to Enter Customary Confidentiality Agreements and Desire to Continue Trading Verso Stock Underscores Company's Concerns
Atlas/Blue Wolf's Abstention on the Pixelle Transaction Has the Same Impact as Voting "Against" and Could Deprive Stockholders of at Least $225 Million of Capital Returns